https://www.businesswire.com/news/home/20221006005843/en/Hugel-Aesthetics-Resubmits-Biologics-License-Application-for-LetibotulinumtoxinA-for-Injection-for-Glabellar-Lines-to-the-FDA
Hugel Aesthetics Resubmits Biologics License Application for LetibotulinumtoxinA for Injection for...
Hugel America, Inc. (Hugel Aesthetics) announced today that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administrati...
biologics license applicationhugelaestheticsletibotulinumtoxinainjection